-Yutaka Nishiwaki Researcher Activity Profile

Research Author Detailed Information 

Yutaka Nishiwaki Publication Rate By Year

Yutaka Nishiwaki has published 12 paper(s) in 2007, 2 paper(s) in 2008, for a total of 14 research publications in total.

Yutaka Y Nishiwaki Author Information

LAST NAME: nishiwaki

FIRST NAME: Yutaka

INITIALS: y

AFFILIATION:

Papers

Yutaka Nishiwaki's Publication Record

1. Breast cancer in first-degree relatives and risk of lung cancer: assessment of the existence of gene sex interactions. Year Published: 2007
Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan.
2. Personalized medicine and proteomics: lessons from non-small cell lung cancer. Year Published: 2007
Respiratory Biological Sciences, AstraZeneca R&D Lund, SE-221 87 Lund, Sweden.
3. Annual abdominal ultrasonographic examination after curative NSCLC resection. Year Published: 2007
Department of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.
4. Detection of unsuspected distant metastases and/or regional nodes by FDG-PET in LD-SCLC scan in apparent limited-disease small-cell lung cancer. Year Published: 2007
Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwanoha 6-5-1, Kashiwa, Chiba 277-8577, Japan. siniho@east.ncc.go.jp
5. Phase II trial of carboplatin and paclitaxel in non-small cell lung cancer patients previously treated with chemotherapy. Year Published: 2007
Division of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan. kyoh@east.ncc.go.jp
6. Traction versus supine side-bending radiographs in determining flexibility: what factors influence these techniques? Year Published: 2007
Department of Orthopedic Surgery, Meijo Hospital, Nagoya, Nagoya, Japan.
7. Exposure to hardly soluble indium compounds in ITO production and recycling plants is a new risk for interstitial lung damage. Year Published: 2007
Dr T Hamaguchi, 35, Shinanomachi, Shinjuku-ku, Tokyo, Japan; drhama@leisure.co.jp.
8. Annual abdominal ultrasonographic examination after curative NSCLC resection. Year Published: 2007
Department of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.
9. Detection of unsuspected distant metastases and/or regional nodes by FDG-PET in LD-SCLC scan in apparent limited-disease small-cell lung cancer. Year Published: 2007
Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwanoha 6-5-1, Kashiwa, Chiba 277-8577, Japan. siniho@east.ncc.go.jp
10. Traction versus supine side-bending radiographs in determining flexibility: what factors influence these techniques? Year Published: 2007
Department of Orthopedic Surgery, Meijo Hospital, Nagoya, Nagoya, Japan.
11. Exposure to hardly soluble indium compounds in ITO production and recycling plants is a new risk for interstitial lung damage. Year Published: 2007
Department of Preventive Medicine and Public Health, School of Medicine, Keio University Tokyo, Japan. drhama@leisure.co.jp
12. Exposure to hardly soluble indium compounds in ITO production and recycling plants is a new risk for interstitial lung damage. Year Published: 2007
Department of Preventive Medicine and Public Health, School of Medicine, Keio University Tokyo, Japan. drhama@leisure.co.jp
13. Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer. Year Published: 2008
1Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
14. Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer. Year Published: 2008
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. isekine@ncc.go.jp